Table 2.
Event | Celecoxib 400 mg b.i.d. (N = 396) |
Ibuprofen 800 mg t.d.s. (N = 396) |
---|---|---|
Any hypertension adverse event (% of patients)§ | 2.7 | 4.2* |
New-onset hypertension (% of patients) | 2.0 | 3.1* |
Aggravated hypertension (% of patients) | 0.8 | 1.2 |
| ||
Withdrawal for hypertension related adverse effects (% of patients)§ | 0.3 | 0.3 |
| ||
Mean change in blood pressure (mmHg) | ||
Systolic | −0.6 | >20* |
Diastolic | −0.7 | 3.2 |
| ||
Increases in blood pressure (% of patients)# | ||
Systolic >20 mmHg from baseline and absolute value > 140 mmHg | 5.0 | 7.0* |
Diastolic >15 mmHg from baseline and absolute value > 90 mmHg | 1.9 | 2.2 |
b.i.d. twice a day; t.d.s. three times a day.
§New-onset or aggravated.
#observed at final clinic visit.
*P <.05 versus celecoxib by Fisher exact test.